Novabay Pharmaceuticals Inc (AMEX:NBY) has a beta value of 2.01 and has seen 2.17 million shares traded in the last trading session. The company, currently valued at $2.62M, closed the last trade at $0.09 per share which meant it -5.65% during that session. The NBY stock price is -2066.67% off its 52-week high price of $1.95 and 0.0% above the 52-week low of $0.09. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.44 million shares traded. The 3-month trading volume is 3.62 million shares.
Novabay Pharmaceuticals Inc (AMEX:NBY) trade information
Sporting -5.65% in the red in last session, the stock has traded in the red over the last five days, when the NBY stock price touched $0.09 or saw a rise of 17.05%. Year-to-date, Novabay Pharmaceuticals Inc shares have moved -57.40%, while the 5-day performance has seen it change -16.60%. Over the past 30 days, the shares of Novabay Pharmaceuticals Inc (AMEX:NBY) have changed -38.24%. Short interest in the company has seen 0.12 million shares shorted with days to cover at 0.06.
Novabay Pharmaceuticals Inc (NBY) estimates and forecasts
Figures show that Novabay Pharmaceuticals Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -79.82% over the past 6 months, with this year growth rate of 87.76%, compared to 9.00% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 70.60% and 89.00% for the next quarter. Revenue growth from the last financial year stood is estimated to be 9.30%.
1 analysts offering their estimates for the company have set an average revenue estimate of $3.56 million for the current quarter. 1 have an estimated revenue figure of $4.15 million for the next quarter concluding in Jun 2024.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 24.47% over the past 5 years.
NBY Dividends
Novabay Pharmaceuticals Inc is expected to release its next earnings report between May 09 and May 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Novabay Pharmaceuticals Inc (AMEX:NBY)’s Major holders
Insiders own 0.53% of the company shares, while shares held by institutions stand at 3.95% with a share float percentage of 3.97%. Investors are also buoyed by the number of investors in a company, with Novabay Pharmaceuticals Inc having a total of 24 institutions that hold shares in the company. The top two institutional holders are Renaissance Technologies, LLC with over 44923.0 shares worth more than $33791.0. As of Jun 29, 2023, Renaissance Technologies, LLC held 1.07% of shares outstanding.
The other major institutional holder is Tower Research Capital LLC (TRC), with the holding of over 11193.0 shares as of Jun 29, 2023. The firm’s total holdings are worth over $8419.0 and represent 0.27% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. As of Jun 29, 2023, the former fund manager holds about 0.24% shares in the company for having 9912.0 shares of worth $7455.0 while later fund manager owns 3965.0 shares of worth $2576.0 as of May 30, 2023, which makes it owner of about 0.09% of company’s outstanding stock.
